Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New and future therapies: Changes in the therapeutic armamentarium for SLE.
Askanase A, Khalili L, Tang W, Mertz P, Scherlinger M, Sebbag E, Chasset F, Felten R, Arnaud L. Askanase A, et al. Best Pract Res Clin Rheumatol. 2023 Dec;37(4):101865. doi: 10.1016/j.berh.2023.101865. Epub 2023 Aug 24. Best Pract Res Clin Rheumatol. 2023. PMID: 37633826 Review.
SLAMF6 compartmentalization enhances T cell functions.
Gartshteyn Y, Askanase AD, Song R, Bukhari S, Dragovich M, Adam K, Mor A. Gartshteyn Y, et al. Among authors: askanase ad. Life Sci Alliance. 2022 Dec 8;6(2):e202201533. doi: 10.26508/lsa.202201533. Print 2023 Feb. Life Sci Alliance. 2022. PMID: 36622343 Free PMC article.
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial.
Askanase AD, D'Cruz D, Kalunian K, Merrill JT, Navarra SV, Cahuzac C, Cornelisse P, Murphy MJ, Strasser DS, Trokan L, Berkani O. Askanase AD, et al. Lancet Rheumatol. 2025 Jan;7(1):e21-e32. doi: 10.1016/S2665-9913(24)00246-7. Epub 2024 Nov 22. Lancet Rheumatol. 2025. PMID: 39586304 Clinical Trial.
Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS.
Dall'Era M, Kalunian K, Solomons N, Truman M, Hodge LS, Yap E, Askanase AD. Dall'Era M, et al. Among authors: askanase ad. Lupus Sci Med. 2024 Nov 9;11(2):e001319. doi: 10.1136/lupus-2024-001319. Lupus Sci Med. 2024. PMID: 39521453 Free PMC article. Clinical Trial.
Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus.
Joyce DP, Berger JS, Guttmann A, Hasan G, Buyon JP, Belmont HM, Salmon J, Askanase A, Bathon J, Geraldino-Pardilla L, Ali Y, Ginzler EM, Putterman C, Gordon C, Helmick CG, Barbour KE, Gold HT, Parton H, Izmirly PM. Joyce DP, et al. Among authors: askanase a. Arthritis Res Ther. 2024 Sep 14;26(1):160. doi: 10.1186/s13075-024-03395-6. Arthritis Res Ther. 2024. PMID: 39272198 Free PMC article.
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials.
Parodis I, Lindblom J, Levy RA, Zen M, Cetrez N, Gomez A, Oon S, Henning C, Khamashta M, Quasny HA, Chauhan D, Askanase A, van Vollenhoven R, Nikpour M. Parodis I, et al. Among authors: askanase a. Lancet Rheumatol. 2024 Nov;6(11):e751-e761. doi: 10.1016/S2665-9913(24)00162-0. Epub 2024 Aug 26. Lancet Rheumatol. 2024. PMID: 39208825 Clinical Trial.
Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Barber MRW, Ugarte-Gil MF, Hanly JG, Urowitz MB, St-Pierre Y, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Pons-Estel BA, Cardwell FS, Alarcón GS, Clarke AE. Barber MRW, et al. Among authors: askanase a. Ann Rheum Dis. 2024 Sep 30;83(10):1295-1303. doi: 10.1136/ard-2024-225613. Ann Rheum Dis. 2024. PMID: 38754981
169 results